Sector Chart Summit Therapeutics Inc.

Equities

SMMT

US86627T1088

Market Closed - Nasdaq 16:30:01 2024-05-31 EDT 5-day change 1st Jan Change
8.685 USD -20.47% Intraday chart for Summit Therapeutics Inc. +156.95% +232.76%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
6.1B - - - - -
106B
24.28B -
21.96B -
18.16B
16.37B